Part of UT Health San Antonio

Part of UT Health San Antonio

You are here

Belqis El Ferjani, MD

Contact

210-567-0777

elferjani@uthscsa.edu

Departments & Divisions

Belqis El Ferjani, MD

Assistant Professor/Clinical

Dr. Belqis El Ferjani is a published, board-certified Hospitalist who joined UT Health San Antonio in December 2024 as an Assistant Professor/Clinical at the Multispecialty and Research Hospital. She earned her Doctor of Medicine from the International Medical and Technology University College of Medicine in Tanzania in 2006 before going on to complete her Internal Medicine residency at Southeast Health Medical Center in Dothan, AL in 2022. Dr. El Ferjani also earned her Master in Health Informatics from the University of Texas Houston School of Biomedical Health Informatics in 2018 and completed a postdoctoral Cardiology fellowship at the Methodist Hospital DeBakey Heart and Vascular Center in 2013.

  • Professional Background

    Education

    • 2018 - Master in Health Informatics - University of Texas School of Biomedical Health Informatics
    • 2006 - Doctor of Medicine - International Medical and Technology University College of Medicine

    Training

    • 2022 - Residency - Internal Medicine - Southeast Health Medical Center
    • 2013 - Postdoctoral Fellowship - Cardiology - Methodist Hospital, DeBakey Heart and Vascular Center

    Appointments

    • 12/2024 - Present - Assistant Professor/Clinical - UT Multispecialty and Research Hospital
    • 08/2022 - 11/2024 - Hospitalist - Southeast Health Medical Center

  • Publications

      Poster Presentations

      Vaghani V, Chandwani S, Hirschmann M, Dibag S, El Ferjani B, Lacerda Landry L, Zhang J, and George S. (September 2018). Computing the Impact of Immunotherapy on the Non-Small Cell Lung Cancer (NSCLC) Therapeutic Landscape. Poster presented at: International Association for the Study of Lung Cancer (IASLC) 19th World Conference on Lung Cancer (WCLC).; Toronto, ON, CAN.

      Williams L, Dibaj S, Chandwani S, Vaghani V, Qiuling S, Hirschmann M, El Ferjani B, Lacerda Landry L, Zhang J, George S. (September 2018). Real-World Patient-Reported Outcome Symptom Assessment of Patients with Metastatic Non-Small Cell Lung Cancer Prior to Treatment. Poster presented at: International Association for the Study of Lung Cancer (IASLC) 19th World Conference on Lung Cancer (WCLC); Toronto, ON, CAN.

  • Clinical

    Board Certifications

    • 2022 - American Board of Internal Medicine